NEW YORK, NY, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Remedia Global is an environmental remediation ...

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...

It’s rare for a dictionary to claim that a word has no definition. But that’s what Dictionary.com said about its recently announced word of the year: “67,” pronounced “six-seven,” the slang term that ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

Specific antibody deficiency (SAD) is an immune system disorder. It occurs when you have normal levels of antibodies but an insufficient immune response to certain types of bacteria. Antibodies, also ...

I'm the princess and the pea when it comes to sofas. My husband will attest that I've had complaints about all four couches we've owned since getting married six years ago. Our first sofa felt flimsy, ...

An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...

Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six months later one stays healthy while the other contracts the virus. A new study ...

A cocktail of antibodies could give us a new weapon to fight seasonal flu and new strains that cause pandemics. The mix protected mice from various strains of influenza, but hasn’t yet been tested in ...

In Define Ventures’ AI investing thesis, released Thursday, the health tech venture fund outlines a vision of artificial intelligence readiness to reengineer healthcare. It’s investing in founders ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by clearing amyloid plaques from the brain, the modality has been dogged by a ...